Archives of Clinical Infectious Diseases

Published by: Kowsar

Prevalence of Herpes Simplex Virus Infection in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran

Saeideh Najafi 1 , * , Masood Ghane 1 , Vahdat Poortahmasebi 2 , Seyed Mohammad Jazayeri 2 and Shahrokh Yousefzadeh-Chabok 3
Authors Information
1 Department of Microbiology, Tonekabon Branch, Islamic Azad University, Tonekabon, IR Iran
2 Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Neurosurgery, Guilan University of Medical Science, Rasht, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e36576
  • Published Online: June 19, 2016
  • Article Type: Research Article
  • Received: January 23, 2016
  • Revised: May 27, 2016
  • Accepted: May 29, 2016
  • DOI: 10.5812/archcid.36576

To Cite: Najafi S, Ghane M, Poortahmasebi V, Jazayeri S M, Yousefzadeh-Chabok S. Prevalence of Herpes Simplex Virus Infection in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran, Arch Clin Infect Dis. 2016 ; 11(3):e36576. doi: 10.5812/archcid.36576.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372(9648): 1502-17[DOI][PubMed]
  • 2. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005; 23: 683-747[DOI][PubMed]
  • 3. Bergstrom T. Several options for antiviral treatment trials in multiple sclerosis--but which targets should be selected? Expert Opin Pharmacother. 2000; 1(6): 1087-90[DOI][PubMed]
  • 4. Pender MP, Burrows SR. Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunology. 2014; 3(10): 27[DOI][PubMed]
  • 5. Najafi S, Ghane M, Yousefzadeh-Chabok S, Amiri M. The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran. Jundishapur J Microbiol. 2016; 9(3): 34158[DOI][PubMed]
  • 6. Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, et al. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol. 2000; 6 Suppl 2-14[PubMed]
  • 7. Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Herpesviruses. In: Jawetz, Melnick, & Adelberg's Medical Microbiology. Lange Medical Books/McGraw-Hill. 2013; : 467-89
  • 8. Al-Dujaili LJ, Clerkin PP, Clement C, McFerrin HE, Bhattacharjee PS, Varnell ED, et al. Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol. 2011; 6(8): 877-907[DOI][PubMed]
  • 9. Bertke AS, Ma A, Margolis MS, Margolis TP. Different mechanisms regulate productive herpes simplex virus 1 (HSV-1) and HSV-2 infections in adult trigeminal neurons. J Virol. 2013; 87(11): 6512-6[DOI][PubMed]
  • 10. Kristensson K, Svennerholm B, Persson L, Vahlne A, Lycke E. Latent herpes simplex virus trigeminal ganglionic infection in mice and demyelination in the central nervous system. J Neurol Sci. 1979; 43(2): 253-63[PubMed]
  • 11. Bergstrom T, Andersen O, Vahlne A. Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis. Ann Neurol. 1989; 26(2): 283-5[DOI][PubMed]
  • 12. Gudnadottir M, Helgadottir H, Bjarnason O, Jonsdottir K. Virus Isolated from the Brain of a Patient with Multiple Sclerosis. Exp Neurol. 1964; 9: 85-95[PubMed]
  • 13. Koros C, Ioannidis A, Acquaviva T, Zoga M, Nikolaou C, Chatzipanagiotou S, et al. HSV1 and 2 detection in the CSF of multiple sclerosis patients by real-time PCR. In Vivo. 2014; 28(6): 1201-5[PubMed]
  • 14. Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol. 1996; 53(2): 125-33[PubMed]
  • 15. Lucotte G, Bathelier C, Lespiaux V, Bali C, Champenois T. Detection and genotyping of herpes simplex virus types 1 and 2 by polymerase chain reaction. Mol Cell Probes. 1995; 9(5): 287-90[PubMed]
  • 16. Schalasta G, Arents A, Schmid M, Braun RW, Enders G. Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection. 2000; 28(2): 85-91[PubMed]
  • 17. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol. 2003; 41(2): 576-80[PubMed]
  • 18. Twagira M, Hadzic N, Smith M, Ramaswamy M, Verma A, Dhawan A, et al. Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation. Eur J Pediatr. 2004; 163(3): 166-9[DOI][PubMed]
  • 19. Roubalova K, Suchankova A, Vı́tek A, Sajdova J. Presence of herpes simplex virus (HSV) in peripheral leukocytes of patient who developed active HSV infection after bone marrow transplantation. J Clin Virology. 2000; 17(1): 37-42[DOI]
  • 20. Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex virus viremia during primary genital infection. J Infect Dis. 2008; 198(1): 31-4[DOI][PubMed]
  • 21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1): 121-7[PubMed]
  • 22. van den Pol AN. Viral infection leading to brain dysfunction: more prevalent than appreciated? Neuron. 2009; 64(1): 17-20[DOI][PubMed]
  • 23. Atkins GJ, McQuaid S, Morris-Downes MM, Galbraith SE, Amor S, Cosby SL, et al. Transient virus infection and multiple sclerosis. Rev Med Virol. 2000; 10(5): 291-303[PubMed]
  • 24. Kollias CM, Huneke RB, Wigdahl B, Jennings SR. Animal models of herpes simplex virus immunity and pathogenesis. J Neurovirol. 2015; 21(1): 8-23[DOI][PubMed]
  • 25. Ferrante P, Castellani P, Barbi M, Bergamini F. The Italian Cooperative Multiple Sclerosis case-control study: preliminary results on viral antibodies. Ital J Neurol Sci. 1987; : 45-50[PubMed]
  • 26. Hawkes CH, Giovannoni G, Keir G, Cunnington M, Thompson EJ. Seroprevalence of herpes simplex virus type 2 in multiple sclerosis. Acta Neurol Scand. 2006; 114(6): 363-7[DOI][PubMed]
  • 27. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, et al. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009; 109(4): 277-82[PubMed]
  • 28. Feng ZJ, Zhao RG, Wang DX. [Relationship between EB virus, Cytomegalo virus, herpes simplex virus and coxsackievirus infection and relapse of multiple sclerosis]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008; 22(6): 472-4[PubMed]
  • 29. Virtanen JO, Jacobson S. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets. 2012; 11(5): 528-44[PubMed]
  • 30. Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, Perron H, et al. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol. 2006; 12(1): 65-71[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments